Upload
asad-bhana
View
6
Download
2
Embed Size (px)
DESCRIPTION
pharma
Citation preview
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحانPassmedicine.com (2014) Pharmacology
بالله اال والقوه والحول اكبر والله االالله والاله لله والحمد الله سبحاندعائكم صالح من .التنسونا
NOTE: Green highlight means correct answer, while pink one means wrong answer.
A 44-year-old Bangladeshi man with a history of mitral stenosis and atrial fibrillation is diagnosed with tuberculosis. He is commenced on anti-tuberculosis therapy. Three weeks after starting treatment his INR has increased to 5.6. Which one of the following medications is most likely to be responsible for this increase?
Pyrazinamide
Isoniazid
Rifampicin
Ethambutol
Streptomycin
Next question
Isoniazid inhibits the P450 system
It is important when answering questions relating to liver enzymes to be sure whether the question is asking about induction or inhibition. Drugs causing induction are often well known and Candidates may rush to give these as the answer. A raised INR is a result of inhibited liver enzymes
1 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
P450 enzyme system
Induction usually requires prolonged exposure to the inducing drug, as opposed to P450 inhibitors, where effects are often seen rapidly
Inducers of the P450 system include
antiepileptics: phenytoin, carbamazepine
barbiturates: phenobarbitone
rifampicin
St John's Wort
chronic alcohol intake
griseofulvin
smoking (affects CYP1A2, reason why smokers require more aminophylline)
Inhibitors of the P450 system include
antibiotics: ciprofloxacin, erythromycin
isoniazid
cimetidine, omeprazole
amiodarone
allopurinol
imidazoles: ketoconazole, fluconazole
SSRIs: fluoxetine, sertraline
ritonavir
sodium valproate
acute alcohol intake
quinupristin
A 56-year-old woman presents to the Emergency Department with central crushing chest pain and ST elevation of 3 mm in leads II, III and aVF. Which one of the following is an
2 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
absolute contraindication to thrombolysis?
History of peptic ulcer disease
Menstruation
Pre-proliferative diabetic retinopathy
Stroke 12 months ago
Known intracranial neoplasm
Next question
Whilst local policies vary, an intracranial neoplasm is considered an absolute contraindication to thrombolysis. The other options are relative contraindications.
Thrombolysis
Thrombolytic drugs activate plasminogen to form plasmin. This in turn degrades fibrin and help breaks up thrombi. They in primarily used in patients who present with a ST elevation myocardial infarction. Other indications include acute ischaemic stroke and pulmonary embolism, although strict inclusion criteria apply.
Examples
alteplase
tenecteplase
streptokinase
Contraindications to thrombolysis
active internal bleeding
recent haemorrhage, trauma or surgery (including dental extraction)
coagulation and bleeding disorders
intracranial neoplasm
3 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
stroke < 3 months
aortic dissection
recent head injury
pregnancy
severe hypertension
Side-effects
haemorrhage
hypotension - more common with streptokinase
allergic reactions may occur with streptokinase
================================================
Nicorandil is most useful in the management of:
Hypertension
Heart failure
Angina
Atrial fibrillation
Acute coronary syndrome
Next question
Nicorandil is a potassium channel activator which has a vasodilatory effect on the coronary arteries. Side-effects include headache, flushingand anal ulceration.
Angina pectoris: drug management
The management of stable angina comprises lifestyle changes, medication, percutaneous coronary intervention and surgery. NICE produced guidelines in 2011 covering the management of stable angina
4 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
Medication
all patients should receive aspirin and a statin in the absence of any contraindication
sublingual glyceryl trinitrate to abort angina attacks
NICE recommend using either a beta-blocker or a calicum channel blocker first-line based on 'comorbidities, contraindications and the person's preference'
if a calcium channel blocker is used as monotherapy a rate-limiting one such as verapamil or diltiazem should be used. If used in combination with a beta-blocker then use a long-acting dihydropyridine calcium-channel blocker (e.g. modified-release nifedipine). Remember that beta-blockers should not be prescribed concurrently with verapamil (risk of complete heart block)
if there is a poor response to initial treatment then medication should be increased to the maximum tolerated dose (e.g. for atenolol 100mg od)
if a patient is still symptomatic after monotherapy with a beta-blocker add a calcium channel blocker and vice versa
if a patient is on monotherapy and cannot tolerate the addition of a calcium channel blocker or a beta-blocker then consider one of the following drugs: a long-acting nitrate, ivabradine, nicorandil or ranolazine
if a patient is taking both a beta-blocker and a calcium-channel blocker then only add a third drug whilst a patient is awaiting assessment for PCI or CABG
Nitrate tolerance
many patients who take nitrates develop tolerance and experience reduced efficacy
the BNF advises that patients who develop tolerance should take the second dose of isosorbide mononitrate after 8 hours, rather than after 12 hours. This allows blood-nitrate levels to fall for 4 hours and maintains effectiveness
this effect is not seen in patients who take modified release isosorbide mononitrate
Ivabradine
a new class of anti-anginal drug which works by reducing the heart rate
acts on the If ('funny') ion current which is highly expressed in the sinoatrial node, reducing cardiac pacemaker activity
adverse effects: visual effects, particular luminous phenomena, are common. Bradycardia, due to the mechanism of action, may also be seen
5 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
there is no evidence currently of superiority over existing treatments of stable angina
===================================================
A 54-year-old man with a history of hypertension comes for review. He currently takes lisinopril 10mg od, simvastatin 40mg on and aspirin 75mg od. His blood pressure is well controlled at 124/76 mmHg but he also mentions that he is due to have a tooth extraction next week. What advice should be given with regards to his aspirin use?
Take aspirin as normal but take tranexamic 1g tds acid 24 hours before and after procedure
Stop 72 hours before, restart 24 hours after procedure
Stop 24 hours before, restart 12 hours after procedure
Take aspirin as normal
Stop 48 hours before, restart 24 hours after procedure
Next question
In the BNF section 'Prescribing in dental practice' it advises that patients in this situation should continue taking anti-platelets as normal
Aspirin
Aspirin works by blocking the action of both cyclooxygenase-1 and 2. Cyclooxygenase is responsible for prostaglandin, prostacyclin and thromboxane synthesis. The blocking of thromboxane A2 formation in platelets reduces the ability of platelets to aggregate which has lead to the widespread use of low-dose aspirin in cardiovascular disease. Until recent guidelines changed all patients with established cardiovascular disease took aspirin if there was no contraindication. Following the 2010 technology appraisal of clopidogrel this is no longer the case*.
Two recent trials (the Aspirin for Asymptomatic Atherosclerosis and the Antithrombotic Trialists Collaboration) have cast doubt on the use of aspirin in primary prevention of cardiovascular disease. Guidelines have not yet changed to reflect this. However the Medicines and Healthcare products Regulatory Agency (MHRA) issued a drug safety update in January 2010 reminding prescribers that aspirin is not licensed for primary prevention.
What do the current guidelines recommend?
first-line for patients with ischaemic heart disease
6 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
Potentiates
oral hypoglycaemics warfarin steroids
*NICE now recommend clopidogrel first-line following an ischaemic stroke and for peripheral arterial disease. For TIAs the situation is more complex. Recent Royal College of Physician (RCP) guidelines support the use of clopidogrel in TIAs. However the older NICE guidelines still recommend aspirin + dipyridamole - a position the RCP state is 'illogical'
==============================================================
In the Vaughan Williams classification of antiarrhythmics verapamil is an example of a:
Class Ia agent
Class Ib agent
Class II agent
Class III agent
Class IV agent
Next question
Antiarrhythmics: Vaughan Williams classification
The Vaughan Williams classification of antiarrhythmics is still widely used although it should be noted that a number of common drugs are not included in the classification e.g. adenosine, atropine, digoxin and magnesium
AP = action potential
Class ExamplesMechanism of action Notes
Ia QuinidineProcainamideDisopyramide
Block sodium channels
Quinidine toxicity causes cinchonism (headache, tinnitus, thrombocytopaenia)
7 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
Class ExamplesMechanism of action Notes
Increases AP duration Procainamide may cause drug-induced
lupus
Ib LidocaineMexiletineTocainide
Block sodium channels
Decreases AP duration
Ic FlecainideEncainidePropafenone
Block sodium channels
No effect on AP duration
II PropranololAtenololBisoprololMetoprolol
Beta-adrenoceptor antagonists
III AmiodaroneSotalolIbutilideBretylium
Block potassium channels
IV Verapamil Diltiazem
Calcium channel blockers
====================================
What is the mechanism of action of heparin?
Activates antithrombin III
Vitamin K antagonist
8 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
Activates tissue plasminogen activator
Inhibits antithrombin III
Inhibits protein C
Next question
Heparin
There are two main types of heparin - unfractionated, 'standard' heparin or low molecular weight heparin (LMWH). Heparins generally act by activating antithrombin III. Unfractionated heparin forms a complex which inhibits thrombin, factors Xa, IXa, XIa and XIIa. LMWH however only increases the action of antithrombin III on factor Xa
The table below shows the differences between standard heparin and LMWH:
Standard heparinLow molecular weight heparin (LMWH)
Administration Intravenous Subcutaneous
Duration of action
Short Long
Mechanism of action
Activates antithrombin III. Forms a complex that inhibits thrombin, factors Xa, IXa, Xia and XIIa
Activates antithrombin III. Forms a complex that inhibits factor Xa
Side-effects BleedingHeparin-induced thrombocytopaenia (HIT)Osteoporosis
Bleeding
Lower risk of HIT and osteoporosis with LMWH
9 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
Standard heparinLow molecular weight heparin (LMWH)
Monitoring Activated partial thromboplastin time (APTT)
Anti-Factor Xa (although routine monitoring is not required)
NotesUseful in situations where there is a high risk of bleeding as anticoagulation can be terminated rapidly
Now standard in the management of venous thromboembolism treatment and prophylaxis and acute coronary syndromes
Heparin-induced thrombocytopaenia (HIT)
immune mediated - antibodies form which cause the activation of platelets
usually does not develop until after 5-10 days of treatment
despite being associated with low platelets HIT is actually a prothrombotic condition
features include a greater than 50% reduction in platelets, thrombosis and skin allergy
treatment options include alternative anticoagulants such as lepirudin and danaparoid
Both unfractionated and low-molecular weight heparin can cause hyperkalaemia. This is thought to be caused by inhibition of aldosterone secretion.
Heparin overdose may be reversed by protamine sulphate, although this only partially reverses the effect of LMWH.
=======================================
A patient is given aspirin 300 mg after developing an acute coronary syndrome. What is the mechanism of action of aspirin to achieve an antiplatelet effect?
Inhibits the production of thromboxane A2
Inhibits ADP binding to its platelet receptor
10 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
Inhibits the production of prostaglandin H2
Glycoprotein IIb/IIIa receptor antagonist
Inhibits the production of prostacyclin (PGI2)
Next question
Acute coronary syndrome: management of NSTEMI
NICE produced guidelines in 2013 on the Secondary prevention in primary and secondary care for patients following a myocardial infarction management of unstable angina and non-ST elevation myocardial infarction (NSTEMI). These superceded the 2010 guidelines which advocated a risk-based approach to management which determined whether drugs such as clopidogrel were given.
All patients should receive
aspirin 300mg
nitrates or morphine to relieve chest pain if required
Whilst it is common that non-hypoxic patients receive oxygen therapy there is little evidence to support this approach. The 2008 British Thoracic Society oxygen therapy guidelines advise not giving oxygen unless the patient is hypoxic.
Antithrombin treatment. Fondaparinux should be offered to patients who are not at a high risk of bleeding and who are not having angiography within the next 24 hours. If angiography is likely within 24 hours or a patients creatinine is > 265 µmol/l unfractionated heparin should be given.
Clopidogrel 300mg should be given to all patients and continued for 12 months.
Intravenous glycoprotein IIb/IIIa receptor antagonists (eptifibatide or tirofiban) should be given to patients who have an intermediate or higher risk of adverse cardiovascular events (predicted 6-month mortality above 3.0%), and who are scheduled to undergo angiography within 96 hours of hospital admission.
11 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
Coronary angiography should be considered within 96 hours of first admissionto hospital to patients who have a predicted 6-month mortality above 3.0%. It should also be performed as soon as possible in patients who are clinically unstable.
The table below summaries the mechanism of action of drugs commonly used in the management of acute coronary syndrome:
Medication Mechanism of action
Aspirin Antiplatelet - inhibits the production of thromboxane A2
Clopidogrel Antiplatelet - inhibits ADP binding to its platelet receptor
Enoxaparin Activates antithrombin III, which in turn potentiates the inhibition of coagulation factors Xa
Fondaparinux Activates antithrombin III, which in turn potentiates the inhibition of coagulation factors Xa
Bivalirudin Reversible direct thrombin inhibitor
12 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
13 | P a g e
http://kaheel7.com/eng/وبحمده العظيم الله سبحان وبحمده الله سبحان
14 | P a g e